Siyavuya ukujoyina iinkokheli zoshishino kwi-CPHI South East Asia 2025, okwenzeka ngoJulayi 16 ukuya kwi-18 e-MITEC e-Kuala Lumpur. Esi siganeko sithatha i-15,000 square metres kwaye siya kubonisa malunga nababonisi be-400. Ngaphezulu kweengcali ze-8,000 ekulindeleke ukuba zizimase, kunye neesemina ze-60 + kunye neeforamu ezigxile kwiindlela zangoku zoshishino, iteknoloji entsha, kunye nophuhliso lolawulo. Lithuba elihle kakhulu lothungelwano kunye nentsebenziswano kulo lonke ikhonkco lokubonelela ngamayeza.

Malunga JYMed
 
I-JYMed yinkampani yoxubo egxile kwipeptide egxile kuphando, uphuhliso, ukuvelisa, kunye norhwebo. Sinikezela ngeenkonzo zeCDMO ezidityaniswe ngokupheleleyo ezilungiselelwe amayeza, ezozithambiso, kunye nabathengi bezilwanyana kwihlabathi liphela.

Ipotfoliyo yethu ibandakanya uluhlu olubanzi lwe-peptide APIs. Iimveliso ze-Flagship ezifana ne-Semaglutide kunye ne-Tirzepatide ziye zagqiba ngempumelelo iifayili ze-US FDA DMF.

I-subsidiary yethu, i-Hubei JXBio, iqhuba imigca yemveliso ye-peptide ye-API eyakhelwe ukuhlangabezana nemigangatho ye-cGMP evela kuzo zombini i-US FDA kunye ne-NMPA yase-China. Esi sibonelelo sibandakanya i-10 enkulu kunye nemigca yemveliso ye-pilot kwaye ixhaswa yiNkqubo yoLawulo loMgangatho oqinileyo (QMS) kunye neeprotokholi zeMpilo yokuSingqongileyo kunye noKhuseleko (EHS).

I-JXBio iphumelele ukuhlolwa kwe-GMP kuzo zombini i-US FDA kunye ne-NMPA yaseTshayina. Siyazingca ukuba samkelwa ngamahlakani ehlabathi ekuxutyweni namachiza ngokugqwesa kumgangatho, ukhuseleko, kunye nokuthotyelwa kokusingqongileyo.

IIMVELISO EZIPHAMBILI

Qhagamshelana nathi
Ngemibuzo, zive ukhululekile ukufikelela kubo:
● Global API & Cosmetic Imibuzo:+ 86-150-1352-9272
● Ubhaliso lwe-API & neeNkonzo zeCDMO (US & EU):+ 86-158-1868-2250
● I-imeyile: jymed@jymedtech.com
● Idilesi:Imigangatho ye-8 & 9, iSakhiwo 1, i-Shenzhen Biomedical Innovation Industrial Park, i-14 Jinhui Road, iSithili saseKengzi, iSithili sasePingshan, iShenzhen, eChina.